Hunan High-Tech Industrial Investment chair Li Aidong visits portfolio company Jianlang Pharma for operations review

PUBT · 2d ago
Hunan High-Tech Industrial Investment chair Li Aidong visits portfolio company Jianlang Pharma for operations review
  • Hunan Pharmaceutical Development PE fund manager’s chair Li Aidong visited portfolio company Jianlang Pharma on Sept. 8, 2026.
  • Site tour covered Jianlang Pharma’s solid-dosage manufacturing workshop, with a review of production processes, operations, business performance, strategy.
  • Management flagged a “critical” turnaround phase, urging faster execution, clearer positioning, market expansion to support higher-quality growth.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hunan Pharmaceutical Development Private Equity Fund Management Co Ltd published the original content used to generate this news brief on September 11, 2026, and is solely responsible for the information contained therein.